The Japanese steelmaker agreed to pay $14.1 billion to buy the Pittsburgh company in 2023. The CEO's embrace of nascent AI technology is a shift from the company's early days when it used ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...

Anne Wojcicki won a bid to purchase the genetic testing platform through her nonprofit TTAM Research Institute. The $305M deal was part of a bankruptcy auction, beating out offers from Regeneron ...

To delete your data from 23andMe, you need to log in to your account and then follow these steps: Navigate to the Settings ...

A nonprofit backed by the DNA-testing firm's former CEO, Anne Wojcicki, bid $305 million to take control of the company.

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

A.I. may push ad creatives from producing to consulting. At Cannes, Monks, a marketing technology agency, will showcase a new ...

Anne Wojcicki, the co-founder and former CEO of 23andMe, will purchase the bankrupt company’s assets for $305 million, the genetic testing company said Friday. Regeneron Pharmaceuticals had agreed to ...

Flying cars may not have arrived yet, but the long-awaited era of everyday robotaxis is here. And not just in America, if I’m ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a higher bid. The private-equity firm plans to bid against rival Advent ...

Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced on ...